Shedir Pharma Group SpA (MIL:SHE) Total Stockholders Equity : €37.57 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shedir Pharma Group SpA Total Stockholders Equity?

Shedir Pharma Group SpA's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €37.57 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Shedir Pharma Group SpA's Book Value per Share for the quarter that ended in Jun. 2024 was €3.31. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Shedir Pharma Group SpA's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.16.

Shedir Pharma Group SpA Total Stockholders Equity Historical Data

The historical data trend for Shedir Pharma Group SpA's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shedir Pharma Group SpA Total Stockholders Equity Chart

Shedir Pharma Group SpA Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

22.56

26.67

28.15

32.77

35.96

Shedir Pharma Group SpA Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial									27.75	32.77	31.64	35.96	37.57

Shedir Pharma Group SpA (MIL:SHE) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Shedir Pharma Group SpA's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(37.574	-	0)	/	11.3625
	=	3.31

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Shedir Pharma Group SpA's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.329	+	3.549)	/	37.574
	=	0.16

Shedir Pharma Group SpA Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shedir Pharma Group SpA's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shedir Pharma Group SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shedir Pharma Group SpA (MIL:SHE) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

95 - Piano di Sorrento, Via Bagnulo, Naples, ITA, 80063

Website

http://www.shedirpharma.com

Shedir Pharma Group SpA is engaged in manufacturing of nutraceuticals, cosmetics and medical devices. Its products are divided into four lines Shedir , Deimos, Phobos, and Menkar. The company's products include capsules, softgels, swallowable and chewable tablets, orosoluble powders, granules, oral solutions, drops for oral use, sprays for oral, sublingual and nasal use, Creams and gels for cosmetic use, and Spray for topical use.